1. Home
  2. BCAB vs SND Comparison

BCAB vs SND Comparison

Compare BCAB & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • SND
  • Stock Information
  • Founded
  • BCAB 2007
  • SND 2011
  • Country
  • BCAB United States
  • SND United States
  • Employees
  • BCAB N/A
  • SND N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • BCAB Health Care
  • SND Industrials
  • Exchange
  • BCAB Nasdaq
  • SND Nasdaq
  • Market Cap
  • BCAB 32.5M
  • SND 95.7M
  • IPO Year
  • BCAB 2020
  • SND 2016
  • Fundamental
  • Price
  • BCAB $0.50
  • SND $2.31
  • Analyst Decision
  • BCAB Buy
  • SND Hold
  • Analyst Count
  • BCAB 2
  • SND 2
  • Target Price
  • BCAB $5.00
  • SND $2.63
  • AVG Volume (30 Days)
  • BCAB 1.7M
  • SND 98.8K
  • Earning Date
  • BCAB 11-07-2024
  • SND 11-12-2024
  • Dividend Yield
  • BCAB N/A
  • SND N/A
  • EPS Growth
  • BCAB N/A
  • SND N/A
  • EPS
  • BCAB N/A
  • SND N/A
  • Revenue
  • BCAB $11,000,000.00
  • SND $281,956,000.00
  • Revenue This Year
  • BCAB N/A
  • SND N/A
  • Revenue Next Year
  • BCAB N/A
  • SND $4.51
  • P/E Ratio
  • BCAB N/A
  • SND N/A
  • Revenue Growth
  • BCAB N/A
  • SND N/A
  • 52 Week Low
  • BCAB $0.45
  • SND $1.65
  • 52 Week High
  • BCAB $4.02
  • SND $2.80
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 21.85
  • SND 53.67
  • Support Level
  • BCAB $0.57
  • SND $2.17
  • Resistance Level
  • BCAB $0.68
  • SND $2.42
  • Average True Range (ATR)
  • BCAB 0.06
  • SND 0.11
  • MACD
  • BCAB 0.01
  • SND 0.01
  • Stochastic Oscillator
  • BCAB 16.67
  • SND 68.57

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About SND Smart Sand Inc.

Smart Sand Inc is a fully integrated frac sand supply and services company that offers complete mine-to-well site proppant supply and logistics solutions. It produces Northern White frac sand, which is a premium proppant used to enhance hydrocarbon recovery rates in the hydraulic fracturing of oil and natural gas wells. Its product portfolio includes Smart System, which includes SmartBelt, SmartDepot Silo and SmartPath Loader. The company caters its products and services to oil and natural gas exploration and production companies and oilfield service companies. The majority of its revenue comes from Sand Sales, followed by logistics.

Share on Social Networks: